23 /100
LOW RISK
Score updated Jul 14, 2026

NHPAP — National Healthcare Properties, Inc. Dilution Risk Tracker

Track NHPAP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NHPAP — Get alerts when the score changes →

As of July 14, 2026, National Healthcare Properties, Inc. (NHPAP) has a DilutionWatch DilutionScore of 23/100, rated LOW dilution risk. National Healthcare Properties, Inc. has 28.41M shares outstanding, 1 institutional holders tracked. Key dilution vectors include approximately 135 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NHPAP.
🔔 Track NHPAP — Get forecast alerts →

💹 Market Data

Market CapN/A
Shares Outstanding28.41M
Float28.26M
Cash$52.81M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 185.1% shares (2025Q4 vs prior)
1 institutional holders · 8.6K shares
#1 NBC SECURITIES, INC. 8.6K shares

📉 Short Interest

Short Interest7.9K
Days to Cover1.3
% of Float0.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

8-K 8K EVENT May 01, 2026
8-K 8K EVENT Apr 27, 2026
EFFECT EFFECT Apr 21, 2026
8-K 8K EVENT Apr 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NHPAP Shareholders

National Healthcare Properties, Inc. (NHPAP) has a DilutionScore of 23/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for NHPAP shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for NHPAP in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for NHPAP alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NHPAP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NHPAP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NHPAP
📊 NHPAP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NHPAP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.